ANI Pharmaceuticals(ANIP)
PRINCETON, NJCDMO (Contract Manufacturing)
Focus: ANI Pharmaceuticals is a public CDMO and generic pharmaceuticals company headquartered in Princeton, NJ, generating $487M in FY2025 revenue with a diversified portfolio of branded generics and contract manufacturing.
Profile data last refreshed 16h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About ANI Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow ANI Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from ANI Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
1 imminent
VEREGEN
Hiring
0 open
Revenue
$487M
FY2025
Key Products
$23MDeclining
LOE Approaching
Flagship product generating one-third of company revenue; generic competition already post-LOE; loss of exclusivity poses material revenue risk.
Help build intelligence for ANI Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.